The independent source for health policy research, polling, and news.
6,541 - 6,560 of 15,443 Results
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.
Older adults who lack a conventional support system should plan ahead to deal with life’s predictable challenges as they age.
Once viewed as a promising cost-control tool, such insurance faces new competition on benefits menus from more traditional insurance. But, according to new research, none of those choices is getting less expensive.
A project that started in a Boston Veterans Affairs facility will soon go nationwide. It puts naloxone, also known as Narcan, into emergency supplies cabinets throughout the VA system.
Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid treatment.
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
Immigrants accounted for nearly 13 percent of premiums paid to private plans but only about 9 percent of insurers’ expenditures, according to a new study in Health Affairs. The cost of care for the group of native-born customers, however, exceeded their premiums.
Students from eight medical schools in and around New York City attended a conference Sept. 23 on progressive activism during their training years — and beyond.
In a Medicaid-funded pilot project starting with 19 counties, clinicians and other providers are now in charge of deciding what kind of treatment an offender needs. The change has rankled some judges and attorneys — and forced some felons to spend more time in jail — but it has been largely embraced by clinicians and county agencies.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administration’s move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.
State legalization efforts, as well as the introduction of edible or vaporized cannabis- infused products, may be contributing to experimentation by teens.
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”
The protection is a win for people who get their needed, legitimate drugs from overseas.
Physicians estimate that 21 percent of medical care is unnecessary — a problem that costs the health care system at least $210 billion a year. KHN hosted a forum on how too much medicine can cause harm.
Medevac helicopter companies are on the radar of an FAA funding bill likely to pass the House and Senate this week.
As Republican and Democratic attorneys general square off on a Texas case that threatens to dismantle consumer protections in the federal health law, campaigns across the country for states’ highest legal officer get hotter.
After an accident in an all-terrain vehicle crushed a doctor’s left arm, he was whisked by air ambulance to the closest trauma center for specialized care. Soon he was fighting over the $56,603 bill.
Penalties will total $566 million for all hospitals. But many that serve a large share of low-income patients will lose less money than they did in previous years.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
© 2026 KFF